# Phase I of XKH001Injection in Healthy Adults

> **NCT05128409** · PHASE1 · UNKNOWN · sponsor: **Beijing Kanova Biopharmaceutical Co., LTD** · enrollment: 35 (estimated)

## Conditions studied

- Healthy Adults

## Interventions

- **DRUG:** XKH001 Injection
- **DRUG:** XKH001Placebo Injection

## Key facts

- **NCT ID:** NCT05128409
- **Lead sponsor:** Beijing Kanova Biopharmaceutical Co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-07
- **Primary completion:** 2024-10-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2023-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05128409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05128409, "Phase I of XKH001Injection in Healthy Adults". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05128409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*